{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:54:26Z","timestamp":1783788866789,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.yrtph.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T20:19:20Z","timestamp":1518639560000},"page":"306-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats \u2013 Comparison of juvenile and adult responses"],"prefix":"10.1016","volume":"94","author":[{"given":"Mark","family":"Collinge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Nilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaher A.","family":"Radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Mark","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2018.02.006_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(80)90579-6","article-title":"Malignant lymphoma in cyclosporin A treated allograft recipients","volume":"1","author":"Bieber","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2018.02.006_bib2","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1038\/ncomms12258","article-title":"Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models","volume":"7","author":"Bottos","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yrtph.2018.02.006_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10915810801978110","article-title":"What's so special about the developing immune system?","volume":"27","author":"Burns-Naas","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/15476910500362937","article-title":"Development of the immune system in the cynomolgus monkey: the appropriate model in human targeted toxicology?","volume":"2","author":"Buse","year":"2005","journal-title":"J. Immunot."},{"key":"10.1016\/j.yrtph.2018.02.006_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0300-483X(02)00614-5","article-title":"Reproductive\/developmental toxicity and immunotoxicity assessment in the nonhuman primate model","volume":"185","author":"Buse","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2018.02.006_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10735-006-9057-2","article-title":"Thymus development in Macaca fascicularis (Cynomolgus monkey): an approach for toxicology and embryology","volume":"37","author":"Buse","year":"2006","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2018.02.006_bib8","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood-2007-09-115030","article-title":"The specificity of JAK3 kinase inhibitors","volume":"111","author":"Changelian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yrtph.2018.02.006_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/toxsci\/kfw197","article-title":"Effects of the Janus kinase inhibitor, tofacitinib, on testicular leydig cell hyperplasia and adenoma in rats, and on prolactin signaling in cultured primary rat leydig cells","volume":"155","author":"Chapin","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2018.02.006_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/1547691X.2012.661486","article-title":"Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations","volume":"9","author":"Collinge","year":"2012","journal-title":"J. Immunot."},{"key":"10.1016\/j.yrtph.2018.02.006_bib11","series-title":"Reproductive Toxicology, 3rd Edition","first-page":"134","article-title":"Developmental immunotoxicology","author":"Collinge","year":"2010"},{"key":"10.1016\/j.yrtph.2018.02.006_bib12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1189\/jlb.0504282","article-title":"The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing","volume":"76","author":"Conklyn","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2014-205847","article-title":"Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme","volume":"75","author":"Curtis","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yrtph.2018.02.006_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.immunol.24.021605.090700","article-title":"Natural killer cell developmental pathways: a question of balance","volume":"24","author":"Di Santo","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2007.02.012","article-title":"B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders","volume":"7","author":"Dolcetti","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.yrtph.2018.02.006_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.113.209304","article-title":"Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis","volume":"348","author":"Dowty","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.yrtph.2018.02.006_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.183.1.195","article-title":"Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model","volume":"183","author":"Foster","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yrtph.2018.02.006_bib18","first-page":"2808","article-title":"Malignant lymphoma in nontransplanted cynomolgus monkeys receiving cyclosporine","volume":"15","author":"Garnett","year":"1983","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.yrtph.2018.02.006_bib19","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yrtph.2018.02.006_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V98.3.877","article-title":"Defective expression of the interleukin-2\/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency","volume":"98","author":"Gilmour","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yrtph.2018.02.006_bib22","first-page":"694","article-title":"STATs in NK-cells: the Good, the bad, and the ugly","volume":"7","author":"Gotthardt","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-60761-401-2_23","article-title":"Immunotoxicity testing in nonhuman primates","volume":"598","author":"Grote-Wessels","year":"2010","journal-title":"Meth. Mol. Biol."},{"issue":"215","key":"10.1016\/j.yrtph.2018.02.006_bib24","first-page":"218","article-title":"Developmental and maturational changes in human blood lymphocyte subpopulations","volume":"13","author":"Hannet","year":"1992","journal-title":"Immunol. today"},{"key":"10.1016\/j.yrtph.2018.02.006_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1191\/0960327102ht294oa","article-title":"The nonhuman primate as a model of developmental immunotoxicity","volume":"21","author":"Hendrickx","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib26","series-title":"Developmental Immunotoxicology","first-page":"117","article-title":"The nonhuman primate as a model of developmental immunotoxicity","author":"Hendrickx","year":"2005"},{"key":"10.1016\/j.yrtph.2018.02.006_bib27","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/bdrb.10035","article-title":"Species comparison of anatomical and functional immune system development","volume":"68","author":"Holsapple","year":"2003","journal-title":"Birth Defects Res. Part B Dev. Reproductive Toxicol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/clin.1994.1023","article-title":"Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements","volume":"70","author":"Hulstaert","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jcp.36.10.1193","article-title":"Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM","volume":"36","author":"Isaacs","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yrtph.2018.02.006_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","article-title":"The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells","volume":"73","author":"Kubo","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yrtph.2018.02.006_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1600-6143.2003.00281.x","article-title":"The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models","volume":"4","author":"Kudlacz","year":"2004","journal-title":"Am. J. Transplant. Official J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.yrtph.2018.02.006_bib35","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.1301000","article-title":"Homeostasis of human NK cells is not IL-15 dependent","volume":"191","author":"Lebrec","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"Jaks and STATs: biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-065X.1995.tb00095.x","article-title":"Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development","volume":"148","author":"Leonard","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yrtph.2018.02.006_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.yrtph.2018.02.006_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis","volume":"24","author":"Ma","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.yrtph.2018.02.006_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/CDLI.10.1.140-153.2003","article-title":"Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development","volume":"10","author":"Makori","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib42","article-title":"Lymphoma in the tofacitinib rheumatoid arthritis clinical development program","author":"Mariette","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.yrtph.2018.02.006_bib43","series-title":"Immunotoxicology Strategies for Pharmaceutical Safety Assessment","first-page":"299","article-title":"Developmental immunotoxicity in nonhuman primates","author":"Martin","year":"2008"},{"key":"10.1016\/j.yrtph.2018.02.006_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0897.2007.00499.x","article-title":"Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system","volume":"58","author":"Martin","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00007890-200201150-00008","article-title":"Posttransplant lymphoproliferative disorder associated with primate gamma-herpesvirus in cynomolgus monkeys used in pig-to-primate renal xenotransplantation and primate renal allotransplantation","volume":"73","author":"McInnes","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.yrtph.2018.02.006_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-9255-7-41","article-title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","volume":"7","author":"Meyer","year":"2010","journal-title":"J. Inflamm."},{"key":"10.1016\/j.yrtph.2018.02.006_bib47","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1073\/pnas.1610253113","article-title":"Network pharmacology of JAK inhibitors","volume":"113","author":"Moodley","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yrtph.2018.02.006_bib48","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.270.5237.800","article-title":"Defective lymphoid development in mice lacking Jak3","volume":"270","author":"Nosaka","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2018.02.006_bib49","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.molimm.2006.11.025","article-title":"Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease","volume":"44","author":"O'Sullivan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib50","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.0802870","article-title":"IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil\/mast cell progenitors in the spleen","volume":"182","author":"Ohmori","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1400063","article-title":"Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts","volume":"193","author":"Onda","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2018.02.006_bib53","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/01.tp.0000177643.05739.cd","article-title":"Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts","volume":"80","author":"Paniagua","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.yrtph.2018.02.006_bib54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.yrtph.2018.02.006_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/1074-7613(95)90066-7","article-title":"Developmental defects of lymphoid cells in Jak3 kinase-deficient mice","volume":"3","author":"Park","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.yrtph.2018.02.006_bib56","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1084\/jem.180.5.1955","article-title":"Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice","volume":"180","author":"Peschon","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yrtph.2018.02.006_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.0105-2896.2005.00220.x","article-title":"Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs","volume":"203","author":"Pesu","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yrtph.2018.02.006_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","article-title":"Therapeutic targeting of Janus kinases","volume":"223","author":"Pesu","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yrtph.2018.02.006_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.168.1.29","article-title":"Development and homeostasis of T cell memory in rhesus macaque","volume":"168","author":"Pitcher","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib60","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/3877","article-title":"Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency","volume":"20","author":"Puel","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yrtph.2018.02.006_bib61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.taap.2013.10.011","article-title":"Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma","volume":"273","author":"Radi","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.yrtph.2012.10.006","article-title":"Human safety risk assessment of lymph node angiomas observed in 2-year carcinogenicity studies in rats","volume":"64","author":"Radi","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yrtph.2017.10.020","article-title":"Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development","volume":"91","author":"Radi","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib64","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood-2002-11-3392","article-title":"IL-15 is an essential mediator of peripheral NK-cell homeostasis","volume":"101","author":"Ranson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yrtph.2018.02.006_bib65","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/JCM.38.9.3219-3225.2000","article-title":"Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections","volume":"38","author":"Rao","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib66","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yrtph.2018.02.006_bib67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-5223(19)37761-X","article-title":"Heart and lung transplantation: autotransplantation and allotransplantation in primates with extended survival","volume":"80","author":"Reitz","year":"1980","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yrtph.2018.02.006_bib68","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1128\/JVI.76.23.12055-12068.2002","article-title":"Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses","volume":"76","author":"Rivailler","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib69","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood-2003-06-2104","article-title":"Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation","volume":"103","author":"Roberts","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yrtph.2018.02.006_bib70","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2018.02.006_bib72","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00007890-200205150-00012","article-title":"Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys","volume":"73","author":"Schmidtko","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.yrtph.2018.02.006_bib73","doi-asserted-by":"crossref","first-page":"677","DOI":"10.18632\/oncoscience.224","article-title":"NK cell modulation by JAK inhibition","volume":"2","author":"Schonberg","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.yrtph.2018.02.006_bib74","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T cell generation","volume":"4","author":"Seder","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib75","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1074-7613(00)00055-8","article-title":"Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function","volume":"13","author":"Shimoda","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.yrtph.2018.02.006_bib77","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-6143.2006.01650.x","article-title":"Epstein-Barr virus: evasive maneuvers in the development of PTLD","volume":"7","author":"Snow","year":"2007","journal-title":"Am. J. Transplant. Official J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.yrtph.2018.02.006_bib78","series-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","first-page":"343","article-title":"Post-transplant lymphoproliferative disorders","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.yrtph.2018.02.006_bib79","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20020066","article-title":"Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells","volume":"195","author":"Tan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yrtph.2018.02.006_bib80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0952-7915(97)80108-2","article-title":"The role of Jak3 in lymphoid development, activation, and signaling","volume":"9","author":"Thomis","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib81","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.270.5237.794","article-title":"Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3","volume":"270","author":"Thomis","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2018.02.006_bib82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12895-015-0025-y","article-title":"Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis","volume":"15","author":"Valenzuela","year":"2015","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.yrtph.2018.02.006_bib83","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","article-title":"Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine","volume":"181","author":"von Freeden-Jeffry","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yrtph.2018.02.006_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molmed.2003.10.005","article-title":"IL-15 in the life and death of lymphocytes: immunotherapeutic implications","volume":"9","author":"Waldmann","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.yrtph.2018.02.006_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ror.0.0010001","article-title":"Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak\/Stat pathway","volume":"1","author":"Watson","year":"1996","journal-title":"Rev. Reprod."},{"key":"10.1016\/j.yrtph.2018.02.006_bib86","first-page":"3101","article-title":"Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels","volume":"23","author":"Wijnen","year":"1991","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.yrtph.2018.02.006_bib87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.yrtph.2018.02.006_bib88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/excr.1999.4673","article-title":"Signal transduction in the erythropoietin receptor system","volume":"253","author":"Wojchowski","year":"1999","journal-title":"Exp. Cell Res."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230018300515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230018300515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T01:06:46Z","timestamp":1603847206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230018300515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":88,"alternative-id":["S0273230018300515"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2018.02.006","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats \u2013 Comparison of juvenile and adult responses","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}